New Medical Therapies for The Treatment of Myelomeningocele by Aamir
Jalal Al Mosawi* in Crimson Publishers: Open access journal of surgery impact
factor
Background: There is no curative or satisfactory effective therapy for the
nervous tissue damage associated with myelomeningocele which generally results
in a serious disability. The aim of this paper is to describe retrospectively
the treatment of four patients with myelomeningocele, three of them were
treated with new therapies.
Patients and methods: During one-year period from June,2018 to June 2019, four patients
with myelomeningocele were
observed. Three of the patients were referred for us for treatment and received
new therapies aiming at treating the nervous tissue damage associated with
myelomeningocele and improving the associated neurological dysfunction. The
fourth observed patient was treated by other physicians mainly with
physiotherapy and received no specific medical therapy. All the patients had
hydrocephalus of variable severity and three of them have already been treated
with a ventriculo-peritoneal shunt. Parenteral cerebrolysin was
used in three patients with the aim of regenerating the spinal cord cells.
Nandrolone decanoate was used in one patient with aim of strengthening muscles
of legs.
Result: Treatment of the three patients resulted in a significant
improvement that has never been reported before with this condition, and
without the occurrence of any side effects. The fourth patients who was not
treated by us didn’t show any improvement.
Conclusion: The use of new therapies for the treatment of myelomeningocele
was found to be very useful and without the occurrence of any side effects.
Study of the use of these therapies in a larger number of patients is
recommended.
For more
open access journals in Crimson Publishers
Please
click on: https://crimsonpublishers.com/
For more
articles on open access journal of
surgery impact factor
Please click on link: https://crimsonpublishers.com/smoaj/index.php
Follow on Publons: https://publons.com/publisher/6342/crimson-publishers
Follow on Linkedin : https://www.linkedin.com/company/crimsonpublishers
No comments:
Post a Comment